348 related articles for article (PubMed ID: 10746637)
21. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.
Weisenburger WP; Hagler AR; Tassinari MS
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):171-84. PubMed ID: 15282738
[TBL] [Abstract][Full Text] [Related]
22. Combined intervention of exercise and genistein prevented androgen deficiency-induced bone loss in mice.
Wu J; Wang XX; Chiba H; Higuchi M; Takasaki M; Ohta A; Ishimi Y
J Appl Physiol (1985); 2003 Jan; 94(1):335-42. PubMed ID: 12486023
[TBL] [Abstract][Full Text] [Related]
23. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.
Franklin M; Bu SY; Lerner MR; Lancaster EA; Bellmer D; Marlow D; Lightfoot SA; Arjmandi BH; Brackett DJ; Lucas EA; Smith BJ
Bone; 2006 Dec; 39(6):1331-42. PubMed ID: 16890505
[TBL] [Abstract][Full Text] [Related]
24. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
[TBL] [Abstract][Full Text] [Related]
25. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
[TBL] [Abstract][Full Text] [Related]
26. Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats.
Gunness M; Orwoll E
J Bone Miner Res; 1995 Nov; 10(11):1735-44. PubMed ID: 8592951
[TBL] [Abstract][Full Text] [Related]
27. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
28. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
29. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats.
Goss PE; Qi S; Cheung AM; Hu H; Mendes M; Pritzker KP
J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):79-87. PubMed ID: 15544933
[TBL] [Abstract][Full Text] [Related]
30. Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats.
Iwamoto J; Takeda T; Katsumata T; Tanaka T; Ichimura S; Toyama Y
Bone; 2002 Feb; 30(2):360-7. PubMed ID: 11856643
[TBL] [Abstract][Full Text] [Related]
31. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
32. Lasofoxifene (CP-336,156), a novel selective estrogen receptor modulator, in preclinical studies.
Ke HZ; Brown TA; Thompson DD
J Am Aging Assoc; 2002 Apr; 25(2):87-99. PubMed ID: 23604900
[TBL] [Abstract][Full Text] [Related]
33. Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat.
Tezval M; Serferaz G; Rack T; Kolios L; Sehmisch S; Schmelz U; Tezval H; Stuermer KM; Stuermer EK
World J Urol; 2011 Aug; 29(4):529-34. PubMed ID: 21298272
[TBL] [Abstract][Full Text] [Related]
34. Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.
Proell V; Xu H; Schüler C; Weber K; Hofbauer LC; Erben RG
Bone; 2009 Oct; 45(4):677-81. PubMed ID: 19501680
[TBL] [Abstract][Full Text] [Related]
35. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats.
Vanderschueren D; van Herck E; Nijs J; Ederveen AG; De Coster R; Bouillon R
Endocrinology; 1997 Jun; 138(6):2301-7. PubMed ID: 9165015
[TBL] [Abstract][Full Text] [Related]
36. Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis.
Gennari L
Drugs Today (Barc); 2006 Jun; 42(6):355-67. PubMed ID: 16845439
[TBL] [Abstract][Full Text] [Related]
37. [Experimental study on effect of anhydroicaritin phytosomes in preventing and treating bone loss and enhancing bone quality in ovariectomized osteoporosis rats].
Wu MS; Zhao SZ; Ren LZ; Wang R; Bai X; Han HW; Li B
Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2163-8. PubMed ID: 24079247
[TBL] [Abstract][Full Text] [Related]
38. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
[TBL] [Abstract][Full Text] [Related]
39. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.
Sato M; McClintock C; Kim J; Turner CH; Bryant HU; Magee D; Slemenda CW
J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401
[TBL] [Abstract][Full Text] [Related]
40. Embryo/fetal toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in rats and rabbits.
Ozolins TR; Gupta U
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):161-70. PubMed ID: 15282737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
